Insider Trading Activity - 5AM Partners IV LLC

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for 5AM Partners IV LLC

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2022-11-11 Sale	2022-11-15 8:32 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	105,281	$2.7381	$288,267	3,907,624 (Indirect)	View
2022-10-31 Sale	2022-11-02 7:49 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	54,209	$2.7688	$150,096	3,911,835 (Indirect)	View
2022-10-06 Sale	2022-10-11 7:10 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	600,000	$4.1482	$2,488,907	410,268 (Indirect)	View
2022-09-14 Sale	2022-09-16 6:03 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	558,168	$1.8764	$1,047,322	3,914,004 (Indirect)	View
2022-09-06 Sale	2022-09-08 8:01 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	770,000	$2.0543	$1,581,835	3,936,331 (Indirect)	View
2022-09-06 Sale	2022-09-08 7:58 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	226,622	$4.8405	$1,096,953	503,112 (Indirect)	View
2022-08-16 Sale	2022-08-18 8:05 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	400,000	$1.6501	$660,060	3,967,131 (Indirect)	View
2022-04-11 Sale	2022-04-13 4:51 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	270,000	$5	$1,350,000	537,301 (Indirect)	View
2020-12-22 Sale	2020-12-28 9:35 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	500,000	$12.82	$6,410,000	181,435 (Indirect)	View
2020-12-14 Sale	2020-12-16 7:15 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	500,000	$12.25	$6,125,915	201,435 (Indirect)	View
2020-11-11 Sale	2020-11-13 8:53 pm	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. ROCKLAGE SCOTT M Former 10% holder 10% Owner	800,000	$13.66	$10,928,000	384,496 (Indirect)	View
2020-10-05 Sale	2020-10-07 9:30 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder	175,000	$25.3	$4,427,500	2,037,654 (Indirect)	View
2020-06-16 Sale	2020-06-18 7:22 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	140,000	$33.3	$4,662,000	313,497 (Indirect)	View
2020-06-11 Sale	2020-06-15 9:12 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	245,000	$28.75	$7,044,412	414,105 (Indirect)	View
2020-05-19 Sale	2020-05-21 9:31 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	255,000	$35.15	$8,963,250	423,905 (Indirect)	View
2019-10-07 Purchase	2019-10-09 6:23 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH 10% Owner	333,333	$15	$4,999,995	333,333 (Indirect)	View
2019-06-21 Sale	2019-06-25 7:03 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. Former 10% holder	250,000	$22.2	$5,550,000	94,489 (Indirect)	View
2019-05-28 Purchase	2019-05-28 8:40 pm	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	750,000	$10	$7,500,000	500,000 (Indirect)	View
2019-05-16 Sale	2019-05-20 4:26 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	615,000	$21.47	$13,204,050	221,435 (Indirect)	View
2019-03-18 Sale	2019-03-20 4:48 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	154,839	$24.25	$3,754,954	104,489 (Indirect)	View
2019-01-22 Sale	2019-01-24 7:01 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	262,153	$21.88	$5,734,597	129,483 (Indirect)	View
2018-12-10 Sale	2018-12-12 8:10 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	15,575	$26.01	$405,029	246,035 (Indirect)	View
2018-11-23 Sale	2018-11-27 6:08 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	29,682	$20.04	$594,709	246,658 (Indirect)	View
2018-11-16 Sale	2018-11-20 5:05 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	525,900	$20.2	$10,623,180	247,845 (Indirect)	View
2018-07-20 Purchase	2018-07-20 7:02 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	115,000	$17	$1,955,000	139,969 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
Ownership	2021-12-13 4:26 pm	N/A N/A	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner	0	$0	18,631,771 (Indirect)	View
2019-10-07 Conversion	2019-10-09 6:23 pm	N/A N/A	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH 10% Owner	2,506,650	$0	333,333 (Indirect)	View
Ownership	2019-10-02 7:31 pm	N/A N/A	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 10% Owner	0	$0	2,519,320 (Indirect)	View
2019-05-28 Conversion	2019-05-28 8:40 pm	N/A N/A	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	2,396,191	$0	500,000 (Indirect)	View
Ownership	2019-05-23 12:21 pm	N/A N/A	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	0	$0	2,713,066 (Indirect)	View
2019-02-20 Other	2019-02-22 8:06 pm	N/A N/A	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	477,363	$0	486,292 (Indirect)	View
2018-07-20 Conversion	2018-07-20 7:02 pm	N/A N/A	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	14,518,556	$0	139,969 (Indirect)	View
Ownership	2018-07-17 8:14 pm	N/A N/A	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	0	$0	3,384,278 (Indirect)	View
2018-04-02 Conversion	2018-04-04 6:41 pm	N/A N/A	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	10,784,074	$0	6,722,076 (Indirect)	View

Insider Trading & Ownership - 5AM Partners IV LLC